- Home
- CMTL vs ALGS Comparison
CMTL vs ALGS Comparison
Compare CMTL & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMTL
- ALGS
- Stock Information
- Founded
- CMTL 1967
- ALGS 2018
- Country
- CMTL United States
- ALGS United States
- Employees
- CMTL N/A
- ALGS N/A
- Industry
- CMTL Radio And Television Broadcasting And Communications Equipment
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- CMTL Technology
- ALGS Health Care
- Exchange
- CMTL Nasdaq
- ALGS Nasdaq
- Market Cap
- CMTL 64.4M
- ALGS 53.0M
- IPO Year
- CMTL N/A
- ALGS 2020
- Fundamental
- Price
- CMTL $2.15
- ALGS $8.04
- Analyst Decision
- CMTL Strong Buy
- ALGS Strong Buy
- Analyst Count
- CMTL 1
- ALGS 1
- Target Price
- CMTL $6.00
- ALGS $70.00
- AVG Volume (30 Days)
- CMTL 191.4K
- ALGS 73.2K
- Earning Date
- CMTL 06-09-2025
- ALGS 08-06-2025
- Dividend Yield
- CMTL N/A
- ALGS N/A
- EPS Growth
- CMTL N/A
- ALGS N/A
- EPS
- CMTL N/A
- ALGS N/A
- Revenue
- CMTL $495,352,000.00
- ALGS $3,270,000.00
- Revenue This Year
- CMTL N/A
- ALGS N/A
- Revenue Next Year
- CMTL N/A
- ALGS $51.55
- P/E Ratio
- CMTL N/A
- ALGS N/A
- Revenue Growth
- CMTL N/A
- ALGS N/A
- 52 Week Low
- CMTL $1.19
- ALGS $3.76
- 52 Week High
- CMTL $5.16
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- CMTL 44.84
- ALGS 52.77
- Support Level
- CMTL $1.97
- ALGS $7.01
- Resistance Level
- CMTL $2.30
- ALGS $9.25
- Average True Range (ATR)
- CMTL 0.16
- ALGS 0.75
- MACD
- CMTL -0.03
- ALGS -0.14
- Stochastic Oscillator
- CMTL 31.75
- ALGS 47.42
About CMTL Comtech Telecommunications Corp.
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.